Targeting GSK-3 family members in the heart: a very sharp double-edged sword.
Cheng, Hui
Targeting GSK-3 family members in the heart: a very sharp double-edged sword. [electronic resource] - Journal of molecular and cellular cardiology Oct 2011 - 607-13 p. digital
Publication Type: Journal Article; Review
1095-8584
10.1016/j.yjmcc.2010.11.020 doi
Animals
Cardiomegaly--drug therapy
Cell Differentiation
Cell Proliferation
Diabetes Mellitus--drug therapy
Embryonic Stem Cells--physiology
Gene Deletion
Glycogen Synthase Kinase 3--antagonists & inhibitors
Humans
Insulin Resistance
Molecular Targeted Therapy
Myocardial Infarction--pathology
Myocardium--metabolism
Myocytes, Cardiac--drug effects
Protein Kinase Inhibitors--pharmacology
Translational Research, Biomedical
Ventricular Remodeling--drug effects
Targeting GSK-3 family members in the heart: a very sharp double-edged sword. [electronic resource] - Journal of molecular and cellular cardiology Oct 2011 - 607-13 p. digital
Publication Type: Journal Article; Review
1095-8584
10.1016/j.yjmcc.2010.11.020 doi
Animals
Cardiomegaly--drug therapy
Cell Differentiation
Cell Proliferation
Diabetes Mellitus--drug therapy
Embryonic Stem Cells--physiology
Gene Deletion
Glycogen Synthase Kinase 3--antagonists & inhibitors
Humans
Insulin Resistance
Molecular Targeted Therapy
Myocardial Infarction--pathology
Myocardium--metabolism
Myocytes, Cardiac--drug effects
Protein Kinase Inhibitors--pharmacology
Translational Research, Biomedical
Ventricular Remodeling--drug effects